Hospital Da Luz is the First in Portugal to Adopt Genesis Robotic System
November 20, 2024 08:18 ET
|
Stereotaxis, Inc.
ST. LOUIS, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that...
Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index
November 13, 2024 08:00 ET
|
PRISM MarketView
Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index
University of Kansas Medical Center Enhances Robotic Heart Care Program with Genesis Robotic Technology
November 06, 2024 08:25 ET
|
Stereotaxis, Inc.
ST. LOUIS, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that...
Positive Long-term Outcomes with HeartFlow FFRCT and Plaque Analysis Demonstrated in ADVANCE-DK Registry at TCT 2024
October 27, 2024 08:15 ET
|
HeartFlow Holding, Inc.
— Data confirm the use of FFRCT and Plaque Analysis helps assess long-term risks, informing more personalized and effective treatment plans for patients with coronary artery disease -– FFRCT further...
Stereotaxis Technology to be Featured at Annual Meeting of the Society for Cardiac Robotic Navigation
October 21, 2024 08:41 ET
|
Stereotaxis, Inc.
ST. LOUIS, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will...
HeartFlow Announces New Category I CPT Code from the American Medical Association for AI-Enabled Plaque Analysis to Assess Risk for Coronary Artery Disease
October 18, 2024 12:39 ET
|
HeartFlow Holding, Inc.
MOUNTAIN VIEW, Calif., Oct. 18, 2024 (GLOBE NEWSWIRE) -- HeartFlow, Inc., the global leader in non-invasive artificial intelligence (AI) heart care solutions, today announced that the American...
Phase III trial results of novel triple combination pill for hypertension published in The Lancet
October 18, 2024 07:00 ET
|
George Medicines
Phase III trial results of novel triple combination pill for hypertension published in The Lancet Novel combination pill significantly reduced blood pressure and improved control rates vs dual...
Winners announced in $300,000 pediatric medical device competition focused on pediatric cardiology
October 15, 2024 15:18 ET
|
Children's National Hospital
WASHINGTON, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Six medical technology innovators focused on pediatric cardiology were selected to receive grants of $50,000 each in the “Make Your Medical Device Pitch...
Tourmaline Bio to Host Expert Webinar on Human Genetic Validation for IL-6 Inhibition in Cardiovascular Disease with Dr. Dipender Gill on Friday, November 1, 2024
October 15, 2024 07:30 ET
|
Tourmaline Bio, Inc.
Tourmaline Bio to Host Expert Webinar on Human Genetic Validation for IL-6 Inhibition in Cardiovascular Disease with Dr. Dipender Gill on Friday, November
Dr. Linda Koshy Joins MyCardiologist, Expanding Cardiovascular Expertise in South Florida
October 15, 2024 05:30 ET
|
My Cardiologist
BOCA RATON, Fla., Oct. 15, 2024 (GLOBE NEWSWIRE) -- MyCardiologist, South Florida's trusted leader in advanced cardiovascular care, is thrilled to announce the addition of Dr. Linda Koshy to their...